pharmaceuticals
pharmaceuticals Articles
Arena Pharmaceuticals shares climbed early on Tuesday after the firm announced positive midstage results from its Phase 2 trial for etrasimod.
Published:
Last Updated:
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates for the rest of March.
Published:
Last Updated:
Bellicum Pharmaceuticals, Inc. (NASDAQ: BLCM) shares made a solid gain on Tuesday after the company announced interim clinical data of BPX-501 in pediatric patients with acute myeloid leukemia (AML)...
Published:
Last Updated:
Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) saw its shares get absolutely crushed in Monday’s session following missed results in a late-stage study. Specifically, the company said that Sollpura...
Published:
Last Updated:
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
Published:
Last Updated:
Mylan has been through the ringer over the past couple of years, but by the looks of it, this stock could be turning around.
Published:
Last Updated:
Valeant Pharmaceuticals saw its shares make a handy gain on Monday after Deutsche Bank upgraded the stock.
Published:
Last Updated:
24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of March.
Published:
Last Updated:
Valeant Pharmaceuticals shares tumbled after it reported its most recent quarterly results early Wednesday.
Published:
Last Updated:
The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical stocks increased.
Published:
Last Updated:
Akorn saw its shares crater on Tuesday after some doubts were cast on its potential acquisition by German health care group Fresnius. This isn’t the first time that Akorn has faced concerns...
Published:
Last Updated:
Tetraphase Pharmaceuticals saw its shares make a solid gain early on Wednesday after the company announced an exclusive licensing agreement in Asia.
Published:
Last Updated:
Here 24/7 Wall St. has included a calendar of a few of the biggest companies expecting clinical trial and FDA updates in February.
Published:
Last Updated:
AbbVie is joining the companies raising their shareholder rewards. The pharmaceutical products maker has announced how it will further commit to previously forecast moves.
Published:
Last Updated:
AMAG Pharmaceuticals saw its shares skyrocket early on Thursday after the company announced that it received an FDA approval.
Published:
Last Updated: